_version_ 1783532992016154624
author Rajaram, Sanjeeth
Canaday, Laura M.
Ochayon, David E.
Rangel, Kelly M.
Ali, Ayad
Gyurova, Ivayla E.
Krishnamurthy, Durga
Fletcher, Jonathan S.
Reighard, Seth D.
Cox, Andrew
Weirauch, Matthew T.
Kottyan, Leah C.
Deshmukh, Hitesh
Zacharias, William J.
Borchers, Michael T.
Waggoner, Stephen N.
author_facet Rajaram, Sanjeeth
Canaday, Laura M.
Ochayon, David E.
Rangel, Kelly M.
Ali, Ayad
Gyurova, Ivayla E.
Krishnamurthy, Durga
Fletcher, Jonathan S.
Reighard, Seth D.
Cox, Andrew
Weirauch, Matthew T.
Kottyan, Leah C.
Deshmukh, Hitesh
Zacharias, William J.
Borchers, Michael T.
Waggoner, Stephen N.
author_sort Rajaram, Sanjeeth
collection PubMed
description
format Online
Article
Text
id pubmed-7219410
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72194102020-05-13 The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection Rajaram, Sanjeeth Canaday, Laura M. Ochayon, David E. Rangel, Kelly M. Ali, Ayad Gyurova, Ivayla E. Krishnamurthy, Durga Fletcher, Jonathan S. Reighard, Seth D. Cox, Andrew Weirauch, Matthew T. Kottyan, Leah C. Deshmukh, Hitesh Zacharias, William J. Borchers, Michael T. Waggoner, Stephen N. Immunity Article Elsevier Inc. 2020-06-16 2020-05-13 /pmc/articles/PMC7219410/ /pubmed/32405233 http://dx.doi.org/10.1016/j.immuni.2020.04.018 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rajaram, Sanjeeth
Canaday, Laura M.
Ochayon, David E.
Rangel, Kelly M.
Ali, Ayad
Gyurova, Ivayla E.
Krishnamurthy, Durga
Fletcher, Jonathan S.
Reighard, Seth D.
Cox, Andrew
Weirauch, Matthew T.
Kottyan, Leah C.
Deshmukh, Hitesh
Zacharias, William J.
Borchers, Michael T.
Waggoner, Stephen N.
The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
title The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
title_full The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
title_fullStr The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
title_full_unstemmed The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
title_short The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
title_sort promise and peril of natural killer cell therapies in pulmonary infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219410/
https://www.ncbi.nlm.nih.gov/pubmed/32405233
http://dx.doi.org/10.1016/j.immuni.2020.04.018
work_keys_str_mv AT rajaramsanjeeth thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT canadaylauram thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT ochayondavide thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT rangelkellym thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT aliayad thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT gyurovaivaylae thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT krishnamurthydurga thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT fletcherjonathans thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT reighardsethd thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT coxandrew thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT weirauchmatthewt thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT kottyanleahc thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT deshmukhhitesh thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT zachariaswilliamj thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT borchersmichaelt thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT waggonerstephenn thepromiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT rajaramsanjeeth promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT canadaylauram promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT ochayondavide promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT rangelkellym promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT aliayad promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT gyurovaivaylae promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT krishnamurthydurga promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT fletcherjonathans promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT reighardsethd promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT coxandrew promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT weirauchmatthewt promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT kottyanleahc promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT deshmukhhitesh promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT zachariaswilliamj promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT borchersmichaelt promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection
AT waggonerstephenn promiseandperilofnaturalkillercelltherapiesinpulmonaryinfection